It has advantages, such as BiTE-mediated T-cell activation being independent of the TCR-MHC interaction, as most immune cell-engaging bispecific antibodies act by binding the CD3ε subunit on T-cells and a TAA on the tumor cell to form a cytolytic synapse. The gene discussed is HLA-C; the disease is neoplasm.